Glycogen synthase kinase-3β inactivation inhibits tumor necrosis factor-α production in microglia by modulating nuclear factor κB and MLK3/JNK signaling cascades
2010

GSK-3β Inactivation Reduces TNF-α Production in Microglia

publication Evidence: moderate

Author Information

Author(s): Wang Mei-Jen, Huang Hsin-Yi, Chen Wu-Fu, Chang Hui-Fen, Kuo Jon-Son

Primary Institution: Buddhist Tzu Chi General Hospital

Hypothesis

How does GSK-3β inactivation affect TNF-α production in microglia?

Conclusion

Inactivation of GSK-3β may be a potential strategy to reduce inflammation in microglia.

Supporting Evidence

  • GSK-3β inhibitors significantly reduced TNF-α production in response to LPS treatment.
  • Loss of GSK-3β activity decreased TNF-α release in microglial cells.
  • GSK-3β inactivation inhibited NF-κB transactivation activity.
  • GSK-3β inhibition blocked JNK signaling, reducing TNF-α production.

Takeaway

When a specific protein called GSK-3β is turned off, it helps reduce a harmful substance called TNF-α that can cause brain inflammation.

Methodology

The study used LPS to induce inflammation in microglial cells and measured TNF-α production using ELISA, along with various signaling analyses.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1742-2094-7-99

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication